Skip to main content

Table 4 Clinical and laboratory characteristics in ICSI cycles, by PCOS phenotype

From: Polycystic ovary syndrome phenotype does not have impact on oocyte morphology

PCOS B (n = 1) was excluded PCOS A
N = 41
PCOS C
N = 31
PCOS D
N = 37
p value Adjusted p
Number of ICSI cycles 77 57 55
Woman’s age during the ICSI cycle 29.6 ± 3,3 29.0 ± 4.3 29.7 ± 3.2 0.48
Protocol:     0.73
 Agonist, n (%) 38 (49.4) 29 (50.9) 24 (43.6)
 Antagonist, n (%) 39 (50.6) 28 (49.1) 31 (56.4)
Number of days of stimulation 12.9 ± 2.5 12.1 ± 2.5 12.1 ± 1.9 0.15
Total dose of FSH, IU 1812 ± 872 2016 ± 1076 1741 ± 700 0.41
Estradiol on hCG day, pg/mL 2666 ± 1454 2363 ± 1387 2382 ± 1206 0.42
Mean number of oocytes retrieved (N) 12.2 ± 6.0 12.1 ± 5.2 11.8 ± 6.2 0.92 0.92
Mean number of MII oocytes (n) 7.8 ± 4.6 8.1 ± 3.6 7.9 ± 4.8 0.91 0.98
Proportion of MII oocytes, n/N (%) 602/939 (64.1) 462/692 (66.8) 432/648 (66.7) 0.85 0.94
  1. Values are quoted as the mean ± standard deviation or n (%)
  2. The p value was adjusted for the woman’s age, BMI and current smoking status, the type of COH protocol, and the total dose of FSH
  3. Abbreviations: FSH follicle-stimulating hormone, MII metaphase II